Drug intelligence / Profile preview

VIT001

Development stage: Preclinical
Lead developer: Vitra Labs
Modality: Cell Therapies

Overview

VIT001 is a preclinical-stage fertility technology being developed by Vitra Labs. It is described as a platform-based ex-vivo maturation system designed to optimize follicle and egg growth outside the body. The primary goal of the technology is to improve the efficiency of in vitro fertilization (IVF) by reducing the number of hormone injections required for patients. Unlike conventional small molecules or biologics, VIT001 functions as a specialized maturation environment for reproductive cells, allowing for the physiological optimization of follicles prior to implantation.

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on VIT001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIT001.

Explore the full profile